- Conditions
- Osteoarthritis
- Interventions
- Synvisc (Hylan G-F20; hyaluronan injection), Bupivicaine (local anesthesia injection), Kenalog (triamcinolone; corticosteroid injection)
- Drug
- Lead sponsor
- Hospital for Special Surgery, New York
- Other
- Eligibility
- 45 Years to 95 Years
- Enrollment
- 200 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2013
- U.S. locations
- 1
- States / cities
- New York, New York
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–13
of 13
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Knee Osteoarthritis
- Interventions
- Synvisc-One Injection, Sham Injection
- Device · Other
- Lead sponsor
- Elaine Husni
- Other
- Eligibility
- 21 Years and older
- Enrollment
- 42 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2015
- U.S. locations
- 1
- States / cities
- Weston, Florida
- Conditions
- Osteoarthritis, Hip, Musculoskeletal Diseases
- Interventions
- Synvisc (hylan G-F 20)
- Device
- Lead sponsor
- Genzyme, a Sanofi Company
- Industry
- Eligibility
- 35 Years and older
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003 – 2006
- U.S. locations
- 32
- States / cities
- Birmingham, Alabama • Huntsville, Alabama • Scottsdale, Arizona + 29 more
- Conditions
- Arthralgia
- Interventions
- Hylan G-F 20, Sham Injection
- Drug · Other
- Lead sponsor
- Grant Jones
- Other
- Eligibility
- 18 Years to 60 Years
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2011
- U.S. locations
- 1
- States / cities
- Columbus, Ohio
- Conditions
- Osteoarthritis
- Interventions
- Synvisc-One (G-F 20)
- Device
- Lead sponsor
- Anthony Luke
- Other
- Eligibility
- 30 Years to 50 Years
- Enrollment
- 51 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2011 – 2019
- U.S. locations
- 1
- States / cities
- San Francisco, California
- Conditions
- Osteoarthritis, Hip
- Interventions
- Synvisc-One (hylan G-F 20), Placebo
- Device
- Lead sponsor
- Genzyme, a Sanofi Company
- Industry
- Eligibility
- 35 Years and older
- Enrollment
- 357 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2015
- U.S. locations
- 45
- States / cities
- Burmingham, Alabama • Phoenix, Arizona • Tucson, Arizona + 41 more
- Conditions
- Osteoarthritis, Knee
- Interventions
- Zilretta, Synvisc-One 48 MG in 6 ML Prefilled Syringe, Monovisc 88 MG Per 4 ML Prefilled Syringe
- Drug
- Lead sponsor
- Ohio State University
- Other
- Eligibility
- 25 Years to 85 Years
- Enrollment
- 6 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2023
- U.S. locations
- 2
- States / cities
- Columbus, Ohio • Lewis Center, Ohio
- Conditions
- Carpometacarpal Osteoarthritis
- Interventions
- Synvisc (hylan G-F20)
- Device
- Lead sponsor
- Hospital for Special Surgery, New York
- Other
- Eligibility
- 45 Years to 95 Years
- Enrollment
- 32 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2009
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Osteoarthritis
- Interventions
- Ketorolac Tromethamine Injection, Methylprednisolone Acetate Injection, Hylan G-F 20
- Drug
- Lead sponsor
- UConn Health
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 18 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2019
- U.S. locations
- 1
- States / cities
- Farmington, Connecticut
- Conditions
- Osteoarthritis, Knee
- Interventions
- hylan G-F 20, 1% sodium hyaluronate
- Device
- Lead sponsor
- American Orthopaedic Society for Sports Medicine
- Other
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 198 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2012
- U.S. locations
- 1
- States / cities
- Portsmouth, Virginia
- Conditions
- Osteoarthritis, Knee
- Interventions
- Hylan F- 20
- Drug
- Lead sponsor
- Steadman Hawkins Research Foundation
- Other
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2008
- U.S. locations
- 1
- States / cities
- Vail, Colorado
- Conditions
- Knee Osteoarthritis
- Interventions
- Hylan G-F 20, Control
- Device · Other
- Lead sponsor
- OhioHealth
- Other
- Eligibility
- 40 Years to 70 Years
- Enrollment
- 9 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2015
- U.S. locations
- 1
- States / cities
- Columbus, Ohio
- Conditions
- Osteoarthritis
- Interventions
- Hylan G-F 20
- Device
- Lead sponsor
- Kessler Foundation
- Other
- Eligibility
- 41 Years and older
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2000 – 2005
- U.S. locations
- 1
- States / cities
- West Orange, New Jersey